Alimera Sciences (ALIM)
(Delayed Data from NSDQ)
$3.63 USD
+0.04 (1.11%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $3.60 -0.03 (-0.83%) 7:58 PM ET
5-Strong Sell of 5 5
D Value B Growth D Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ALIM 3.63 +0.04(1.11%)
Will ALIM be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for ALIM based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ALIM
New Strong Sell Stocks for March 13th
Alimera Sciences (ALIM) Reports Q4 Loss, Tops Revenue Estimates
ALIM: What are Zacks experts saying now?
Zacks Private Portfolio Services
Novavax (NVAX) Reports Q4 Loss, Lags Revenue Estimates
Alimera Sciences (ALIM) Reports Q3 Loss, Misses Revenue Estimates
Alimera Sciences (ALIM) Reports Q2 Loss, Lags Revenue Estimates
Other News for ALIM
Analysts Offer Insights on Healthcare Companies: BioLife Solutions (BLFS) and Alimera (ALIM)
Alimera Sciences initiated with bullish view at Maxim
The top stocks with buying pressure across the Russell universe - Jefferies
Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Alimera Sciences reports inducement grants under Nasdaq listing rule